H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 10 650 KRW 0.28% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
HLB Life Science Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
Growth Rates:
1 Year
-5%
3 Years
+69%
5 Years
-13%
7 Years
-10%
10 Years
+261%
Operating Income
+
Growth Rates:
1 Year
+29%
3 Years
-159%
5 Years
-143%
7 Years
-
10 Years
-1 640%
Net Income
+
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
+4 443%
10 Years
-

Earnings Waterfall
HLB Life Science Co Ltd

Revenue
97.1B KRW
Cost of Revenue
-99.9B KRW
Gross Profit
-2.8B KRW
Operating Expenses
-23.8B KRW
Operating Income
-26.6B KRW
Other Expenses
97.7B KRW
Net Income
71B KRW

Income Statement
HLB Life Science Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
26 921
N/A
36 560
+36%
36 580
+0%
34 739
-5%
29 033
-16%
27 323
-6%
29 191
+7%
25 730
-12%
20 970
-18%
42 234
+101%
59 517
+41%
84 642
+42%
108 191
+28%
106 445
-2%
106 930
+0%
103 643
-3%
105 040
+1%
102 476
-2%
105 436
+3%
107 875
+2%
111 640
+3%
114 019
+2%
118 918
+4%
112 472
-5%
102 427
-9%
91 797
-10%
70 599
-23%
62 918
-11%
57 296
-9%
53 494
-7%
58 848
+10%
61 067
+4%
87 628
+43%
99 591
+14%
114 798
+15%
120 360
+5%
101 918
-15%
97 990
-4%
90 719
-7%
92 870
+2%
97 109
+5%
Gross Profit
Cost of Revenue
(25 440)
(31 331)
(32 536)
(34 877)
(31 427)
(31 813)
(32 957)
(26 236)
(20 592)
(38 933)
(55 340)
(79 304)
(101 565)
(101 031)
(101 393)
(98 402)
(99 623)
(97 806)
(100 091)
(102 963)
(109 435)
(106 412)
(112 774)
(106 508)
(94 392)
(89 470)
(68 501)
(61 021)
(55 639)
(59 031)
(62 072)
(65 982)
(93 465)
(102 638)
(118 004)
(122 921)
(104 679)
(98 739)
(93 482)
(95 416)
(99 914)
Gross Profit
1 480
N/A
5 230
+253%
4 043
-23%
(139)
N/A
(2 394)
-1 622%
(4 489)
-88%
(3 767)
+16%
(506)
+87%
378
N/A
3 301
+773%
4 178
+27%
5 338
+28%
6 626
+24%
5 414
-18%
5 538
+2%
5 242
-5%
5 418
+3%
4 670
-14%
5 344
+14%
4 911
-8%
2 203
-55%
7 607
+245%
6 143
-19%
5 963
-3%
8 035
+35%
2 326
-71%
2 098
-10%
1 897
-10%
1 657
-13%
(5 537)
N/A
(3 224)
+42%
(4 915)
-52%
(5 838)
-19%
(3 046)
+48%
(3 206)
-5%
(2 561)
+20%
(2 761)
-8%
(749)
+73%
(2 763)
-269%
(2 546)
+8%
(2 805)
-10%
Operating Income
Operating Expenses
(3 013)
(3 778)
(4 012)
(4 257)
(4 212)
(5 206)
(4 804)
(4 288)
(7 212)
(4 699)
(5 455)
(5 911)
(5 640)
(4 425)
(5 159)
(7 005)
(8 661)
(12 633)
(13 055)
(13 107)
(13 170)
(12 086)
(12 250)
(11 299)
(10 747)
(10 393)
(10 141)
(11 569)
(11 926)
(12 943)
(27 444)
(13 476)
(15 683)
(17 115)
(18 724)
(21 246)
(34 571)
(23 784)
(24 848)
(24 423)
(23 831)
Selling, General & Administrative
(2 669)
(3 355)
(3 410)
(3 624)
(3 479)
(4 337)
(4 044)
(3 680)
(4 154)
(4 452)
(5 153)
(5 476)
(5 349)
(3 874)
(5 018)
(6 614)
(7 884)
(11 070)
(10 896)
(10 451)
(10 442)
(9 162)
(9 224)
(8 793)
(8 359)
(8 058)
(7 848)
(8 051)
(8 036)
(8 343)
(8 597)
(8 992)
(10 801)
(11 245)
(12 553)
(14 002)
(14 141)
(15 599)
(16 186)
(16 479)
(16 206)
Research & Development
(93)
(24)
(99)
(46)
(64)
(352)
0
0
0
(81)
(81)
(163)
(251)
(243)
(297)
(548)
(939)
(1 321)
(1 630)
(1 804)
(1 703)
(1 429)
(1 464)
(1 188)
(1 124)
(1 431)
(1 527)
(2 704)
(3 087)
(3 846)
(4 316)
(3 759)
(4 008)
(4 349)
(4 274)
(4 679)
(4 670)
(5 454)
(5 749)
(5 732)
(5 768)
Depreciation & Amortization
(248)
(398)
(501)
(586)
(669)
(517)
(412)
(299)
(188)
(166)
(222)
(273)
(336)
(308)
(295)
(294)
(289)
(242)
(529)
(852)
(1 025)
(1 495)
(1 562)
(1 318)
(1 263)
(905)
(767)
(814)
(804)
(755)
(745)
(726)
(875)
(1 521)
(1 915)
(2 582)
(3 070)
(2 730)
(2 659)
(2 212)
(1 857)
Other Operating Expenses
(3)
0
0
0
0
0
(348)
(309)
(2 870)
0
0
0
296
0
451
451
451
0
0
0
0
0
0
0
0
0
0
0
0
0
(13 786)
0
0
0
17
17
(12 690)
0
(254)
0
0
Operating Income
(1 531)
N/A
1 451
N/A
33
-98%
(4 394)
N/A
(6 605)
-50%
(9 696)
-47%
(8 569)
+12%
(4 793)
+44%
(6 833)
-43%
(1 398)
+80%
(1 278)
+9%
(575)
+55%
984
N/A
989
+1%
376
-62%
(1 765)
N/A
(3 246)
-84%
(7 963)
-145%
(7 712)
+3%
(8 197)
-6%
(10 967)
-34%
(4 479)
+59%
(6 107)
-36%
(5 336)
+13%
(2 712)
+49%
(8 066)
-197%
(8 044)
+0%
(9 673)
-20%
(10 270)
-6%
(18 480)
-80%
(30 667)
-66%
(18 391)
+40%
(21 521)
-17%
(20 161)
+6%
(21 930)
-9%
(23 807)
-9%
(37 333)
-57%
(24 533)
+34%
(27 611)
-13%
(26 970)
+2%
(26 635)
+1%
Pre-Tax Income
Interest Income Expense
(97)
(465)
(353)
(396)
(409)
(783)
(663)
(490)
(692)
(1 492)
(1 948)
(2 428)
(2 266)
7 679
7 788
12 715
14 320
4 149
(1 260)
(7 640)
(17 038)
31 393
7 840
12 926
32 891
(17 812)
(18 006)
(34 474)
3 391
(21 544)
(17 998)
6 441
(31 186)
(28 889)
(3 905)
(18 751)
(39 728)
59 640
190 076
55 464
134 239
Non-Reccuring Items
0
0
0
(1 345)
(1 828)
(4 452)
(4 408)
(3 063)
0
(14)
295
295
0
803
0
0
0
0
0
0
0
(33 126)
0
0
0
(32 489)
0
0
0
(13 785)
0
(13 782)
(16 088)
(14 761)
(14 755)
(15 013)
0
(40 975)
0
0
1
Gain/Loss on Disposition of Assets
147
123
(20)
(31)
(25)
2
(3)
0
0
6
8
10
0
4
0
0
0
(37)
0
0
0
(38)
0
0
0
313
0
(18)
(12)
95
0
120
4 394
3 157
3 105
2 728
0
(305)
0
0
0
Total Other Income
17
205
366
(1 332)
(1 447)
(1 914)
(2 064)
(533)
(477)
1 685
1 796
1 843
1 927
(1 641)
(1 357)
(1 185)
(1 076)
581
151
(251)
(197)
(311)
(27 050)
(26 897)
(25 537)
1 564
(20 462)
(20 656)
(22 305)
90
139
357
286
(184)
(285)
(288)
(4 073)
(330)
(36 639)
(35 632)
(33 222)
Pre-Tax Income
(1 464)
N/A
1 315
N/A
28
-98%
(7 497)
N/A
(10 313)
-38%
(16 843)
-63%
(15 706)
+7%
(8 878)
+43%
(8 002)
+10%
(1 212)
+85%
(1 127)
+7%
(854)
+24%
645
N/A
7 834
+1 115%
6 807
-13%
9 765
+43%
9 998
+2%
(3 270)
N/A
(8 822)
-170%
(16 089)
-82%
(28 203)
-75%
(6 561)
+77%
(25 317)
-286%
(19 308)
+24%
4 641
N/A
(56 490)
N/A
(46 512)
+18%
(64 819)
-39%
(29 195)
+55%
(53 624)
-84%
(48 526)
+10%
(25 255)
+48%
(64 115)
-154%
(60 839)
+5%
(37 770)
+38%
(55 131)
-46%
(81 135)
-47%
(6 503)
+92%
125 826
N/A
(7 138)
N/A
74 383
N/A
Net Income
Tax Provision
(131)
17
17
(180)
(180)
(198)
(199)
(2)
(2)
(39)
(47)
(52)
(80)
(73)
(127)
(179)
(101)
(28)
10
(247)
(377)
(1 002)
(964)
(660)
(610)
654
621
735
812
4 333
4 343
4 357
7 257
6 479
7 499
8 444
6 646
590
(37)
(1 981)
(3 132)
Income from Continuing Operations
(1 595)
1 331
44
(7 677)
(10 493)
(17 041)
(15 904)
(8 880)
(8 004)
(1 251)
(1 175)
(906)
565
7 761
6 681
9 586
9 897
(3 299)
(8 811)
(16 335)
(28 579)
(7 563)
(26 282)
(19 968)
4 031
(55 836)
(45 890)
(64 084)
(28 383)
(49 292)
(44 183)
(20 899)
(56 858)
(54 360)
(30 271)
(46 687)
(74 489)
(5 913)
125 789
(9 119)
71 251
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
39
233
248
295
376
(42)
15
(97)
(223)
39
1
86
(14)
140
138
65
159
82
21
61
79
(70)
(334)
(85)
(204)
Net Income (Common)
(1 152)
N/A
1 403
N/A
44
-97%
(7 677)
N/A
(10 493)
-37%
(17 041)
-62%
(16 897)
+1%
(10 499)
+38%
(9 628)
+8%
(1 251)
+87%
(802)
+36%
35
N/A
1 564
+4 369%
7 761
+396%
7 301
-6%
10 291
+41%
10 561
+3%
(3 066)
N/A
(8 564)
-179%
(16 041)
-87%
(28 204)
-76%
(7 605)
+73%
(26 267)
-245%
(20 065)
+24%
3 809
N/A
(55 797)
N/A
(45 888)
+18%
(63 997)
-39%
(28 397)
+56%
(49 152)
-73%
(44 045)
+10%
(20 834)
+53%
(56 700)
-172%
(54 277)
+4%
(30 251)
+44%
(46 626)
-54%
(74 410)
-60%
(5 983)
+92%
125 455
N/A
(9 205)
N/A
71 046
N/A
EPS (Diluted)
-39.72
N/A
50.1
N/A
1.51
-97%
-264.72
N/A
-338.48
-28%
-501.2
-48%
-331.31
+34%
-205.86
+38%
-188.78
+8%
-24.52
+87%
-15.72
+36%
0.68
N/A
30.66
+4 409%
152.17
+396%
128.08
-16%
180.54
+41%
207.07
+15%
-53.78
N/A
-114.18
-112%
-172.48
-51%
-300.04
-74%
-86.42
+71%
-279.43
-223%
-213.45
+24%
45.34
N/A
-593.58
N/A
-487.23
+18%
-679.51
-39%
-286.69
+58%
-467.42
-63%
-438.54
+6%
-207.26
+53%
-557.74
-169%
-507.86
+9%
-314.48
+38%
-458.15
-46%
-711.1
-55%
-55.54
+92%
1 102.23
N/A
-84.94
N/A
655.61
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 216,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.